FeedbackEfavirenz should be used as the preferred non-nucleoside reverse transcriptase inhibitor in patients
starting ART while on antituberculosis treatment.
Grade Certainty of evidence
Grade Strength
Grade Certainty of evidence label
Recommendation Direction